Brief: AC Immune Presents First In Vivo Images Of Brain Tdp-43 Pathology From Phase 1 Trial Of Pet Tracer Aci-19626, At Ad/Pdtm 2026
19/03/2026 12:08
March 19 (Reuters) - AC Immune SA ACIU.O: AC IMMUNE PRESENTS FIRST IN VIVO IMAGES OF BRAIN TDP-43 PATHOLOGY FROM PHASE 1 TRIAL OF PET TRACER ACI-19626, AT AD/PDTM 2026 Source text: ID:nGNX2CR4tQ Further company coverage: ACIU.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on AC Immune AG
See all newsAC Immune rises after Parkinson's drug shows promise in mid-stage trial
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health